MCID: LYM006
MIFTS: 45

Lymphoepithelioma-Like Carcinoma

Categories: Cancer diseases, Immune diseases

Aliases & Classifications for Lymphoepithelioma-Like Carcinoma

MalaCards integrated aliases for Lymphoepithelioma-Like Carcinoma:

Name: Lymphoepithelioma-Like Carcinoma 12 15
Lymphoepithelial Carcinoma 12 73
Nasopharyngeal Type Undifferentiated Carcinoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:5660
NCIt 50 C4107
SNOMED-CT 68 7300000
UMLS 73 C0334254

Summaries for Lymphoepithelioma-Like Carcinoma

Disease Ontology : 12 A carcinoma that is a malignant epithelial neoplasm densely infiltrated by lymphoid cells.

MalaCards based summary : Lymphoepithelioma-Like Carcinoma, also known as lymphoepithelial carcinoma, is related to basal cell carcinoma and intrahepatic cholangiocarcinoma. An important gene associated with Lymphoepithelioma-Like Carcinoma is KRT7 (Keratin 7), and among its related pathways/superpathways are Keratinization and Cytoskeletal Signaling. The drugs Gemcitabine and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include lung, skin and cervix, and related phenotypes are Decreased shRNA abundance (Z-score < -2) and Decreased shRNA abundance (Z-score < -2)

Wikipedia : 76 Lymphoepithelioma-like carcinoma (LELC) is a medical term referring to a histological variant of... more...

Related Diseases for Lymphoepithelioma-Like Carcinoma

Diseases related to Lymphoepithelioma-Like Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 291)
# Related Disease Score Top Affiliating Genes
1 basal cell carcinoma 30.0 KRT20 KRT7 KRT8
2 intrahepatic cholangiocarcinoma 29.9 CDH1 KRT7 MUC1
3 papilloma 29.8 KRT20 KRT5 KRT7 KRT8
4 papillary carcinoma 29.1 CDH1 KRT20 KRT7 MUC1
5 adenosquamous carcinoma 28.5 KRT18 KRT5 KRT7 KRT8 MUC1
6 cholangiocarcinoma 27.7 CDH1 KRT18 KRT20 KRT7 KRT8 MUC1
7 cervical lymphoepithelioma-like carcinoma 12.3
8 infiltrating bladder lymphoepithelioma-like carcinoma 12.3
9 lymphoepithelioma-like thymic carcinoma 11.4
10 solid adenocarcinoma with mucin production 10.9 KRT7 MUC1
11 endosalpingiosis 10.8 KRT7 MUC1
12 parachordoma 10.8 KRT7 MUC1
13 malignant mixed mullerian tumor 10.8 KRT7 MUC1
14 nodular hidradenoma 10.8 KRT7 MUC1
15 cystic basal cell carcinoma 10.8 KRT20 KRT7
16 monophasic synovial sarcoma 10.8 KRT7 MUC1
17 nephrogenic adenoma 10.8 KRT7 MUC1
18 vaginal benign neoplasm 10.8 KRT20 KRT7
19 seminal vesicle adenocarcinoma 10.8 KRT20 KRT7
20 transverse colon cancer 10.8 KRT20 KRT7
21 adenomyoma 10.8 KRT7 MUC1
22 appendix adenocarcinoma 10.8 KRT20 KRT7
23 ovarian large-cell neuroendocrine carcinoma 10.8 KRT20 KRT7
24 vaginal adenoma 10.8 KRT20 KRT7
25 vaginal tubulovillous adenoma 10.8 KRT20 KRT7
26 spiradenoma 10.8 KRT7 MUC1
27 eyelid neoplasm 10.8 KRT20 KRT7
28 glandular cystitis 10.8 KRT20 KRT7
29 malignant syringoma 10.8 KRT20 KRT7
30 krukenberg carcinoma 10.8 KRT20 KRT7
31 lung acinar adenocarcinoma 10.8 KRT20 KRT7
32 eccrine sweat gland neoplasm 10.8 KRT20 KRT7
33 hidradenoma 10.8 KRT7 MUC1
34 vulval paget's disease 10.8 KRT20 KRT7
35 intratubular embryonal carcinoma 10.8 KRT20 KRT7
36 pilomatrix carcinoma 10.8 ENO2 MUC1
37 ovarian mucinous adenocarcinoma 10.8 KRT20 KRT7
38 well-differentiated liposarcoma 10.7 KRT7 MUC1
39 thymus adenocarcinoma 10.7 KRT20 KRT7
40 intracranial cysts 10.7 ENO2 MUC1
41 meibomian cyst 10.7 KRT20 KRT7
42 bladder lymphoma 10.7 KRT20 KRT7
43 sertoli-leydig cell tumor 10.7 KRT7 MUC1
44 papillary serous adenocarcinoma 10.7 KRT20 KRT7
45 bladder adenocarcinoma 10.7 KRT20 KRT7
46 sinonasal undifferentiated carcinoma 10.7 ENO2 MUC1
47 jejunal adenocarcinoma 10.7 KRT20 KRT7
48 chronic cystitis 10.7 KRT20 KRT7
49 vulva adenocarcinoma 10.7 KRT20 KRT7
50 medulloepithelioma 10.7 KRT20 KRT7

Graphical network of the top 20 diseases related to Lymphoepithelioma-Like Carcinoma:



Diseases related to Lymphoepithelioma-Like Carcinoma

Symptoms & Phenotypes for Lymphoepithelioma-Like Carcinoma

GenomeRNAi Phenotypes related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

26 (show all 12)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased shRNA abundance (Z-score < -2) GR00366-A-153 9.58 KRT5
2 Decreased shRNA abundance (Z-score < -2) GR00366-A-154 9.58 KRT18
3 Decreased shRNA abundance (Z-score < -2) GR00366-A-17 9.58 KRT18 KRT5
4 Decreased shRNA abundance (Z-score < -2) GR00366-A-180 9.58 KRT5 KRT8
5 Decreased shRNA abundance (Z-score < -2) GR00366-A-200 9.58 KRT5
6 Decreased shRNA abundance (Z-score < -2) GR00366-A-33 9.58 KRT18
7 Decreased shRNA abundance (Z-score < -2) GR00366-A-40 9.58 KRT8
8 Decreased shRNA abundance (Z-score < -2) GR00366-A-68 9.58 KRT7
9 Decreased shRNA abundance (Z-score < -2) GR00366-A-71 9.58 KRT18 KRT5 KRT7 KRT8
10 Decreased shRNA abundance (Z-score < -2) GR00366-A-72 9.58 KRT7
11 Decreased shRNA abundance (Z-score < -2) GR00366-A-84 9.58 KRT18
12 Decreased shRNA abundance (Z-score < -2) GR00366-A-91 9.58 KRT5 KRT7

Drugs & Therapeutics for Lymphoepithelioma-Like Carcinoma

Drugs for Lymphoepithelioma-Like Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 174)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Gemcitabine Approved Phase 2, Phase 3,Phase 1 95058-81-4 60750
2
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
3
Carboplatin Approved Phase 2, Phase 3,Phase 1 41575-94-4 10339178 498142 38904
4
Paclitaxel Approved, Vet_approved Phase 2, Phase 3,Phase 3,Phase 1 33069-62-4 36314
5
Docetaxel Approved, Investigational Phase 3,Phase 2,Phase 1 114977-28-5 148124
6
Fluorouracil Approved Phase 3,Phase 2,Phase 1 51-21-8 3385
7
Lenograstim Approved, Investigational Phase 3,Phase 2,Phase 1 135968-09-1
8
Fluconazole Approved, Investigational Phase 2, Phase 3 86386-73-4 3365
9
Cevimeline Approved Phase 3 107233-08-9 83898 25137844
10
Miconazole Approved, Investigational, Vet_approved Phase 2, Phase 3,Phase 1 22916-47-8 4189
11
Megestrol acetate Approved, Investigational, Vet_approved Phase 3 595-33-5 11683
12
Histamine Approved, Investigational Phase 3 75614-87-8, 51-45-6 774
13
Amifostine Approved, Investigational Phase 3,Phase 2 20537-88-6 2141
14
Doxepin Approved, Investigational Phase 3 1668-19-5 667477 667468
15
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
16 Porfiromycin Investigational Phase 3 801-52-5
17 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
18 Analgesics Phase 3,Phase 2
19 Albumin-Bound Paclitaxel Phase 2, Phase 3,Phase 3,Phase 1
20 Neurotransmitter Agents Phase 3,Phase 2,Not Applicable
21 Cytochrome P-450 Enzyme Inhibitors Phase 2, Phase 3
22 Nucleic Acid Synthesis Inhibitors Phase 3,Phase 2,Phase 1
23 Peripheral Nervous System Agents Phase 3,Phase 2,Not Applicable
24 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
25 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
26 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
27 Anti-Infective Agents Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
28 Liver Extracts Phase 3,Phase 2,Phase 1
29 Antimetabolites Phase 3,Phase 2,Phase 1
30 Antiviral Agents Phase 2, Phase 3,Phase 1,Not Applicable
31 Autonomic Agents Phase 3,Phase 2,Not Applicable
32 Antimetabolites, Antineoplastic Phase 3,Phase 2,Phase 1
33 Antimitotic Agents Phase 2, Phase 3,Phase 3,Phase 1
34 Antineoplastic Agents, Phytogenic Phase 2, Phase 3,Phase 3,Phase 1
35
Cobalt Phase 3 7440-48-4 104729
36
Megestrol Phase 3 3562-63-8 19090 3080587
37
Histamine Phosphate Phase 3 51-74-1 65513
38 Alkylating Agents Phase 3,Phase 2
39 Central Nervous System Depressants Phase 3
40 Adjuvants, Anesthesia Phase 3
41 Adjuvants, Immunologic Phase 3,Phase 2,Phase 1
42 Central Nervous System Stimulants Phase 3,Not Applicable
43 Mitomycins Phase 3
44 Cholinergic Agents Phase 3,Not Applicable
45 Narcotics Phase 3
46 Steroid Synthesis Inhibitors Phase 2, Phase 3
47 Contraceptive Agents Phase 3
48 Contraceptives, Oral Phase 3
49 Histamine Antagonists Phase 3
50 Analgesics, Opioid Phase 3

Interventional clinical trials:

(show top 50) (show all 93)
# Name Status NCT ID Phase Drugs
1 Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx Unknown status NCT00003637 Phase 3 cisplatin;fluorouracil
2 Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer Completed NCT00274937 Phase 3 amifostine trihydrate;fluorouracil;cisplatin
3 Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy Completed NCT01156142 Phase 3 doxepin hydrochloride
4 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
5 Acupuncture or Standard Therapy in Treating Pain and Dysfunction in Patients Who Have Undergone Neck Surgery for Head and Neck Cancer Completed NCT00090337 Phase 3
6 Radiation Therapy and Chemotherapy in Treating Patients With Head and Neck Cancer Completed NCT00002507 Phase 3 mitomycin C;porfiromycin
7 Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer Completed NCT00002533 Phase 2, Phase 3 fluconazole
8 Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer Completed NCT00017511 Phase 3 cevimeline hydrochloride
9 Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer Completed NCT00006799 Phase 3 megestrol acetate
10 Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract Completed NCT00765440 Phase 3
11 Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck Completed NCT00771641 Phase 3
12 Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC Active, not recruiting NCT00997906 Phase 2, Phase 3 carboplatin,;cisplatin;gemcitabine hydrochloride;paclitaxel
13 Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery Terminated NCT00113399 Phase 3 cisplatin;docetaxel;fluorouracil;paclitaxel
14 Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery Withdrawn NCT00041171 Phase 3 Hypericum perforatum;docetaxel
15 Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal Cancer Unknown status NCT00690872 Phase 2 carboplatin;gemcitabine hydrochloride
16 Vaccine Therapy and Celecoxib in Treating Patients With Metastatic Nasopharyngeal Cancer Unknown status NCT00589186 Phase 2 celecoxib
17 Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer Unknown status NCT00093665 Phase 2 cisplatin;fluorouracil
18 Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer Unknown status NCT00625937 Phase 2 cisplatin;docetaxel;tegafur-gimeracil-oteracil potassium
19 Cisplatin-Epinephrine Injectable Gel Plus Paclitaxel and Carboplatin in Treating Patients With Recurrent Head and Neck Cancer Unknown status NCT00022217 Phase 2 carboplatin;cisplatin-e therapeutic implant;paclitaxel
20 External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases Unknown status NCT00637637 Phase 2 indinavir sulfate;ritonavir
21 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx Unknown status NCT00004094 Phase 2 carboplatin;fluorouracil;hydroxyurea;paclitaxel
22 Cetuximab (ERBITUX®) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer Unknown status NCT00468169 Phase 2 Cetuximab
23 Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer Unknown status NCT00387530 Phase 2 oral sodium phenylbutyrate;valganciclovir
24 Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck Completed NCT00084318 Phase 2 cisplatin;docetaxel
25 Imatinib Mesylate in Treating Patients With Salivary Gland Cancer Completed NCT00045669 Phase 2 imatinib mesylate
26 Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer Completed NCT00454142 Phase 2 pazopanib hydrochloride
27 Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Completed NCT00492089 Phase 2 bevacizumab;placebo
28 Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer Completed NCT00101348 Phase 1, Phase 2 erlotinib hydrochloride
29 High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer Completed NCT00052429 Phase 1, Phase 2 cisplatin;fluorouracil
30 Chemotherapy in Treating Patients With Solid Tumors Completed NCT00003103 Phase 1, Phase 2 docetaxel
31 High-dose ICE With Amifostine Completed NCT00003657 Phase 2 Amifostine;Carboplatin;Etoposide;Ifosfamide
32 Docetaxel in Treating Patients With Solid Tumors Completed NCT00003565 Phase 2 docetaxel
33 Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer Completed NCT00448552 Phase 2 capecitabine;oxaliplatin
34 Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer Completed NCT00004901 Phase 1, Phase 2 ethynyluracil;fluorouracil;hydroxyurea
35 Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor Completed NCT00021047 Phase 1, Phase 2 capecitabine;carboplatin;epirubicin hydrochloride
36 Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors Completed NCT00019331 Phase 2 DetoxPC
37 Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer Completed NCT00509665 Phase 2 doxorubicin hydrochloride;gemcitabine hydrochloride
38 Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer Completed NCT00021333 Phase 2 cisplatin;paclitaxel
39 Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer Completed NCT00002515 Phase 2 carboplatin;thiotepa;topotecan hydrochloride
40 Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC) Recruiting NCT00896181 Phase 2 docetaxel;cisplatin;carboplatin;fluorouracil
41 18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy Active, not recruiting NCT01806675 Phase 1, Phase 2 fludeoxyglucose F 18;2-fluoropropionyl-labeled pegylated dimeric RGD peptide
42 Functional MRI in Finding Hypoxia in Patients Undergoing Chemotherapy and Radiation Therapy for Stage III or Stage IV Head and Neck Cancer Unknown status NCT00896350 Phase 1 chemotherapy
43 Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer Completed NCT01637194 Phase 1 everolimus
44 Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors Completed NCT00089362 Phase 1 alvespimycin hydrochloride
45 Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer Completed NCT00023959 Phase 1 hydroxyurea;fluorouracil
46 Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer Completed NCT00397384 Phase 1 cetuximab;erlotinib hydrochloride
47 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) Completed NCT00031681 Phase 1 7-hydroxystaurosporine;irinotecan hydrochloride
48 Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction Completed NCT00030498 Phase 1 erlotinib hydrochloride
49 Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors Completed NCT01172028 Phase 1 Taxotere (Docetaxel);Alimta (Pemetrexed)
50 Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx Completed NCT00918762 Phase 1

Search NIH Clinical Center for Lymphoepithelioma-Like Carcinoma

Genetic Tests for Lymphoepithelioma-Like Carcinoma

Anatomical Context for Lymphoepithelioma-Like Carcinoma

MalaCards organs/tissues related to Lymphoepithelioma-Like Carcinoma:

41
Lung, Skin, Cervix, Brain, Liver, Salivary Gland, Breast

Publications for Lymphoepithelioma-Like Carcinoma

Articles related to Lymphoepithelioma-Like Carcinoma:

(show top 50) (show all 330)
# Title Authors Year
1
Correlation and prognostic significance of PD-L1 and P53 expression in resected primary pulmonary lymphoepithelioma-like carcinoma. ( 29707344 )
2018
2
Primary pulmonary lymphoepithelioma-like carcinoma in non-endemic region: A case report and literature review. ( 29465599 )
2018
3
Lymphoepithelioma-like carcinoma of the endometrium: Case report of a rare tumour with comprehensive immunohistochemical and molecular analysis. ( 29895132 )
2018
4
PIK3CA and p53 Mutations by Next Generation Sequencing in Lymphoepithelioma-Like Carcinoma of the Endometrium. ( 29854528 )
2018
5
Clinical Significance of Plasma Epstein-Barr Virus DNA in Pulmonary Lymphoepithelioma-like Carcinoma (LELC) Patients. ( 29191777 )
2018
6
Lymphoepithelioma-like carcinoma of the skin. ( 29723365 )
2018
7
Primary pulmonary lymphoepithelioma-like carcinoma in Singapore. ( 29387253 )
2018
8
Pulmonary Lymphoepithelioma-like Carcinoma Disguised as Squamous Cell Carcinoma. ( 29703540 )
2018
9
Lung cavity accompanied by hemoptysis:Lymphoepithelioma-like carcinoma. ( 29722879 )
2018
10
Prognosis and distribution of lymph nodes metastases in resectable primary pulmonary lymphoepithelioma-like carcinoma: A large cohort from a single center. ( 29327422 )
2018
11
About a case of lymphoepithelioma-like carcinoma of the bladder. ( 29556475 )
2018
12
Lymphoepithelioma-like carcinoma of the large intestine: A case report and literature review. ( 29290316 )
2018
13
Expression of PD-L1/PD-1 in lymphoepithelioma-like carcinoma of the thymus. ( 29973653 )
2018
14
Lymphoepithelioma-Like Carcinoma of the Esophagus: A Rare Tumor. ( 28969745 )
2017
15
(18)F-FDG PET/CT of common hepatic duct lymphoepithelioma-like carcinoma. ( 27836588 )
2017
16
Primary pure lymphoepithelioma-like carcinoma of the ureter. ( 28699107 )
2017
17
Lymphoepithelioma-like carcinoma of the ureter: a rare presentation, synchronous with conventional urothelial carcinoma. ( 28263136 )
2017
18
Lymphoepithelioma-Like Carcinoma of the Breast Mimicking Granulomatous Mastitis- Case Report and Review of the Literature ( 28749097 )
2017
19
Advanced primary pulmonary lymphoepithelioma-like carcinoma: clinical manifestations, treatment, and outcome. ( 28203414 )
2017
20
Lymphoepithelioma-like carcinoma of the urinary bladder: A case report. ( 29179966 )
2017
21
Primary Pulmonary Lymphoepithelioma-like Carcinoma on FDG PET/CT. ( 28250863 )
2017
22
Lymphoepithelioma-Like Carcinoma in Liver. ( 28500863 )
2017
23
Human Papillomavirus (HPV)-associated Lymphoepithelioma-like Carcinoma of the Vagina and Anal Canal: A Rare Variant of Squamous Cell Carcinoma. ( 29257037 )
2017
24
In reply to: letter to the editor entitled: primary pure lymphoepithelioma-like carcinoma of the ureter. ( 28844115 )
2017
25
Lymphoepithelioma-like carcinoma of the upper urinary tract. ( 28455741 )
2017
26
Primary lymphoepithelioma-like carcinoma of the urinary bladder. ( 28757780 )
2017
27
Lymphoepithelioma-like carcinoma of the uterine cervix. ( 28217683 )
2017
28
Lymphoepithelioma-like Carcinoma of the Uterine Cervix: Cytomorphologic Features and Diagnostic Pitfalls by Liquid-Based Cytology. ( 29218797 )
2017
29
Lymphoepithelioma-like carcinoma of cervix: Cytological Features on Conventional Cervical Smear. ( 28211234 )
2017
30
Inflammatory Stroma of Lymphoepithelioma-like Carcinoma of the Cervix: Immunohistochemical Study of 3 Cases and Review of the Literature. ( 28985196 )
2017
31
Collision of Lymphoepithelioma-like Carcinoma with Diffuse Large B-cell Lymphoma of the Stomach: A Case Report. ( 28739754 )
2017
32
Response of advanced stage recurrent lymphoepithelioma-like carcinoma to nivolumab. ( 28971752 )
2017
33
Primary lymphoepithelioma-like carcinoma of the lung: An unusual cancer and clinical outcomes of 14 patients. ( 28928848 )
2017
34
(18)F-FDG PET/CT in gastric lymphoepithelioma-like carcinoma. ( 26746813 )
2016
35
Surgical treatment for primary pulmonary lymphoepithelioma-like carcinoma. ( 26993476 )
2016
36
Pure Lymphoepithelioma-Like Carcinoma Originating from the Urinary Bladder. ( 27099604 )
2016
37
Clinicopathological features and prognosis of primary pulmonary lymphoepithelioma-like carcinoma. ( 27747015 )
2016
38
A case of lymphoepithelioma-like carcinoma of the uterine cervix in a patient with a history of high-grade squamous intraepithelial lesion. ( 27343338 )
2016
39
Lymphoepithelioma-like carcinoma of the bladder: A case report. ( 27377093 )
2016
40
Lymphoepithelioma-like Carcinoma (LELC) of the Prostate. ( 26977409 )
2016
41
Utility of 18F-FDG PET/CT in the assessment of lymphoepithelioma-like carcinoma. ( 26741291 )
2016
42
Primary Lymphoepithelioma-Like Carcinoma of the Prostate Gland: A Review of the Literature. ( 26881187 )
2016
43
Lymphoepithelioma-Like Carcinoma of the Skin-A Rare Tumor Treated by Slow Mohs Micrographic Surgery. ( 27846013 )
2016
44
Pulmonary lymphoepithelioma-like carcinoma with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK) fusion gene. ( 28031835 )
2016
45
Cytological features of lymphoepithelioma-like carcinoma of the breast. ( 27478161 )
2016
46
Extensive Metastases on 18F-FDG PET/CT in Primary Lymphoepithelioma-Like Carcinoma of the Ovary. ( 27607167 )
2016
47
Lymphoepithelioma-like carcinoma of breast-evaluation for Epstein-Barr virus-encoded RNA, human papillomavirus, and markers of basal cell differentiation. ( 27806845 )
2016
48
An Unusual Case of Lymphoepithelioma-Like Carcinoma of the External Auditory Canal. ( 27755455 )
2016
49
Unusual presentation of pulmonary lymphoepithelioma-like carcinoma. ( 27516893 )
2016
50
Metastatic lymphoepithelioma-like carcinoma of the lung treated with nivolumab: a case report and focused review of literature. ( 28149767 )
2016

Variations for Lymphoepithelioma-Like Carcinoma

Expression for Lymphoepithelioma-Like Carcinoma

Search GEO for disease gene expression data for Lymphoepithelioma-Like Carcinoma.

Pathways for Lymphoepithelioma-Like Carcinoma

Pathways related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.81 KRT18 KRT20 KRT5 KRT7 KRT8
2 11.66 CDH1 KRT18 KRT20 KRT5 KRT7 KRT8
3 11.59 CD274 CDH1 PDCD1
4
Show member pathways
11.49 KRT18 KRT5 KRT7 KRT8

GO Terms for Lymphoepithelioma-Like Carcinoma

Cellular components related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular exosome GO:0070062 9.76 CD274 CDH1 ENO2 KRT18 KRT5 KRT7
2 keratin filament GO:0045095 9.26 KRT18 KRT5 KRT7 KRT8
3 intermediate filament GO:0005882 9.02 KRT18 KRT20 KRT5 KRT7 KRT8

Biological processes related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 keratinization GO:0031424 9.35 KRT18 KRT20 KRT5 KRT7 KRT8
2 hepatocyte apoptotic process GO:0097284 9.16 KRT18 KRT8
3 cornification GO:0070268 9.02 KRT18 KRT20 KRT5 KRT7 KRT8

Molecular functions related to Lymphoepithelioma-Like Carcinoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 structural molecule activity GO:0005198 9.13 KRT18 KRT7 KRT8
2 scaffold protein binding GO:0097110 8.8 KRT18 KRT5 KRT8

Sources for Lymphoepithelioma-Like Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....